Drug Type AAV based gene therapy |
Synonyms IVB 501, IVB501 |
Target |
Action modulators |
Mechanism FGF21 modulators(Fibroblast growth factor 21 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
disorder of aging | Preclinical | China | 29 Jan 2024 | |
Nonalcoholic Steatohepatitis | Discovery | China | 01 May 2025 |